www.law360.com/cases/5aa1c7563206a65a4f000001

Parties, docket activity and news coverage of federal case AMGEN INC. et al v. ADELLO BIOLOGICS LLC, case number 2:18-cv-03347, from New Jersey Court.

www.bigmoleculewatch.com/wp-content/uploads/2018/06/DI-37-JDP.pdf

Jun 15, 2018 ... Amgen Inc., et al. v. Adello Biologics, LLC. Civil Action No. 2:18-cv-03347 (CCC)( MF). Dear Judge Falk: This firm, together with Paul, Weiss, ...

www.bigmoleculewatch.com/2018/12/06/amneal-seeks-dismissal-as-defendant-in-amgen-v-adello-filgrastim-biosimilar-suit

Dec 6, 2018 ... In March this year, Amgen sued Adello Biologics under the BPCIA in the District of New Jersey for infringement of seventeen patents, based on ...

www.biologicsblog.com/amgen-v-adello-a-blind-biosimilar-infringement-lawsuit

Apr 9, 2018 ... Last month, Amgen sued Adello Biologics, a US-based biosimilar maker, for patent infringement under the Biologics Price Competition and ...

www.biosimilarsip.com/2018/05/29/litigation-spotlight-the-adello-filgrastim-neupogen-litigation

May 29, 2018 ... On March 8, 2018, Amgen Inc. (“Amgen”) filed suit against Adello Biologics, LLC ( “Adello”) ... asserting counterclaims of non-infringement and invalidity for all seventeen patents. Relying on the Supreme Court's Sandoz, Inc. v.

www.businesswire.com/news/home/20170911005971/en/FDA-Accepts-Adello-Biologic%E2%80%99s-Biosimilar-Biologics-License

Sep 11, 2017 ... Adello Biologics today announced that U.S. FDA accepted the ... About Adello Biologics LLC. Adello is a ... Neupogen® is a registered trademark of Amgen Inc. ... Search All; Search News; Search Site; Advanced News Search.

investors.amgen.com/phoenix.zhtml?c=61656&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTEyMzcyNzUzJkRTRVE9MSZTRVE9MzAmU1FERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw%3D%3D

Jul 27, 2018 ... ... into the existing consolidated case Onyx Therapeutics, Inc. v. Cipla Limited, et al., the lawsuits that were filed against Dr. Reddy's Laboratories, ... As previously disclosed, Amgen Inc. and Amgen Manufacturing Ltd. (collectively, ... Court for the District of New Jersey against Adello Biologics, LLC (Adello).

www.patentdocs.org/2018/10/ptab-life-sciences-report.html

Oct 18, 2018 ... Data Engine Technologies LLC v. Google ... Further, Petitioner asserts that a published, double-blind, placebo-controlled clinical trial by Olesen et al. that associated CGRP blockade with ... Adello Biologics, LLC v. Amgen Inc.

illinoislawreview.org/online/volume-2018/follow-on-biologics-are-set-up-to-fail

Apr 27, 2018 ... Follow-On Biologics Are Set Up to Fail ..... Virtually all states that have passed biologics substitution legislation only allow ...... Amgen Inc. et al v. ..... Adello Biologics' unnamed filgrastim biosimilar, Rixathon/GP2013 (rituximab ...